Evidence map›Paper›PMID 35581701›Full record

ReviewJournal of pharmacy practice2023

Efficacy and Safety of Sitagliptin in the Treatment of COVID-19.

Ehab Mudher Mikhael, Siew Chin Ong, Siti Maisharah Sheikh Ghadzi

Open access · greenAbstract readReview
In one paragraph

Review in Journal of pharmacy practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ehab Mudher MikhaelSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.ORCID 0000-0002-6341-4978
Siew Chin OngSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
Siti Maisharah Sheikh GhadziSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
Universiti Sains Malaysia · MYUniversity of Baghdad · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Diabetes Mellitus, Type 2Dipeptidyl-Peptidase IV InhibitorsHumansSitagliptin PhosphateTreatment OutcomeDipeptidyl-Peptidase IV InhibitorsSitagliptin PhosphateSitagliptin; COVID-19

Identifiers

PMID35581701
PMCPMC9121144
OpenAlexW4280616409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.